🔔 📢 Key Takeaways from the CDDF-ESMO Joint Session, “Regulatory Challenges in Clinical Cancer Drug Development” (16 Sep 2024)
The CDDF & ESMO educational session on “Regulatory Challenges in Clinical Cancer Drug Development” took place on 16 September 2024 at ESMO 2024. In this session, Aaron E. Sosa Mejia (Danish Medicines Agency) and Audrey Wolf (EFPIA) gave presentations...![[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]](https://cddf.org/wp-content/uploads/2024/09/Copy-of-Copy-of-Copy-of-Dark-Purple-and-Blue-Texture-Blur-Circle-Business-Marketing-Presentation-1080x675.jpg)
[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]
We are delighted to announce that the Cancer Drug Development Forum (CDDF) has launched its initiative on diversity in oncology clinical trials. CDDF cordially invites pharmaceutical companies to participate in this collaborative effort to support the planning and...
ACT EU: Stakeholder Presentation on Critical Use-Cases at MSP Advisory Group Meeting (4 July 2024)
On 4 July 2024, CDDF participated in a stakeholder presentation focused on critical use-cases at Multi-Stakeholder Platform (MSP) Advisory Group meeting. The session aimed to identify and discuss real-world challenges faced by stakeholder groups within the European...![[🔔 📢 Key Takeaways from the CDDF Webinar on “Bayesian Approaches in Drug Development”]](https://cddf.org/wp-content/uploads/2024/07/Capture-4-1080x675.jpg)